Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Serious adverse events · patients with induction of remission in ulcerative colitis

Etrolizumab showed no clear difference in serious adverse events compared with placebo (low certainty).

1 finding from 1 review

Etrolizumab for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 0.92 [0.36, 2.34]
2 studies · 165 participants
Low